Stifel Nicolaus reduced its rating on Coventry Health Care CVH from Buy to Hold and removed its previous $37 price target on shares.
Stifel Nicolaus noted, "After many long years of referring to Coventry (CVH) as a "takeout", we and many others were right. On August 20, 2012, Aetna announced a definitive agreement to acquire CVH in a cash and stock deal valuing the company at ~$42 per share. … Given the pending sale to AET, we are downgrading shares to Hold."
Coventry Health Care closed at $41.41 on Monday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in